We are live on ! Find out more
RLWM

RF&L Wealth Management Portfolio holdings

AUM $148M
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+23.72%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$110M
AUM Growth
+$6.41M
Cap. Flow
+$18.7K
Cap. Flow %
0.02%
Top 10 Hldgs %
60.41%
Holding
52
New
2
Increased
13
Reduced
18
Closed

Sector Composition

Rank Sector Weight
1 Technology 10.8%
2 Healthcare 6.06%
3 Consumer Discretionary 3.36%
4 Consumer Staples 3.31%
5 Communication Services 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFEM icon
51
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$8.62B
$210K 0.19%
+8,725
New +$207K
MGK icon
52
Vanguard Mega Cap Growth ETF
MGK
$31.4B
$201K 0.18%
+4,275
New +$184K

Similar funds

RF&L Wealth Management's Q2 2023 Portfolio in Review

As of Q2 2023, RF&L Wealth Management held 52 positions worth $110M, up 6.2% from $103M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.8%. RF&L Wealth Management opened 2 new positions and made no exits, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • RF&L Wealth Management's largest Q2 2023 buy was Dimensional Emerging Markets Core Equity 2 ETF: 8,725 shares worth $210K.
  • RF&L Wealth Management added most to Dimensional US Targeted Value ETF in Q2 2023, an estimated $345K increase.
  • RF&L Wealth Management's biggest Q2 2023 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $235K.
  • RF&L Wealth Management's ten largest holdings make up 60% of its $110M portfolio in Q2 2023.
  • RF&L Wealth Management opened 2 new positions and closed 0 in Q2 2023.
  • RF&L Wealth Management's portfolio value rose 6.2% quarter-over-quarter to $110M.

Based on RF&L Wealth Management's 13F filing for Q2 2023, filed 27 Jul 2023.